Achieving early metabolic control in adults with type diabetes mellitus in Peru

Descripción del Articulo

Objective: To estimate the rate of subjects with type 2 diabetes mellitus (T2DM) who reach the therapy goal for HbA1C one year after diagnosis (early metabolic control). Methods: This was a retrospective study reviewing clinical records of adults who came to sixteen health centers distributed in nin...

Descripción completa

Detalles Bibliográficos
Autores: Rocca Nación, Jesus, Sanchez, Celinda, Bardales, Darío, González Alfaro, Juan, Torres Samamé, Liliana, Burga, José Luis, Olmos, Cecil, Torres-Aparcana, Harold, Barreda, Luis, Delgado, Cesar, Garcia, Alfredo, Noriega-Ruiz, Víctor, Antezana, Antezana, Orengo, Juan C., La Rosa, Alberto M., Pinzón, Adolfo, Gonzalez, Claudio
Formato: artículo
Fecha de Publicación:2023
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/2554
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2554
Nivel de acceso:acceso abierto
Materia:Diabetes Mellitus
Type 2
Glycated Hemoglobin
Follow-Up Studies
Peru
id REVCMP_0ffb00c2882daa9af3073cc893a179c7
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2554
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
dc.title.none.fl_str_mv Achieving early metabolic control in adults with type diabetes mellitus in Peru
Logro de control metabólico temprano en adultos con diabetes mellitus tipo 2 en Perú
title Achieving early metabolic control in adults with type diabetes mellitus in Peru
spellingShingle Achieving early metabolic control in adults with type diabetes mellitus in Peru
Rocca Nación, Jesus
Diabetes Mellitus
Type 2
Glycated Hemoglobin
Follow-Up Studies
Peru
title_short Achieving early metabolic control in adults with type diabetes mellitus in Peru
title_full Achieving early metabolic control in adults with type diabetes mellitus in Peru
title_fullStr Achieving early metabolic control in adults with type diabetes mellitus in Peru
title_full_unstemmed Achieving early metabolic control in adults with type diabetes mellitus in Peru
title_sort Achieving early metabolic control in adults with type diabetes mellitus in Peru
dc.creator.none.fl_str_mv Rocca Nación, Jesus
Sanchez, Celinda
Bardales, Darío
González Alfaro, Juan
Torres Samamé, Liliana
Burga, José Luis
Olmos, Cecil
Torres-Aparcana, Harold
Barreda, Luis
Delgado, Cesar
Garcia, Alfredo
Noriega-Ruiz, Víctor
Antezana, Antezana
Orengo, Juan C.
La Rosa, Alberto M.
Pinzón, Adolfo
Gonzalez, Claudio
author Rocca Nación, Jesus
author_facet Rocca Nación, Jesus
Sanchez, Celinda
Bardales, Darío
González Alfaro, Juan
Torres Samamé, Liliana
Burga, José Luis
Olmos, Cecil
Torres-Aparcana, Harold
Barreda, Luis
Delgado, Cesar
Garcia, Alfredo
Noriega-Ruiz, Víctor
Antezana, Antezana
Orengo, Juan C.
La Rosa, Alberto M.
Pinzón, Adolfo
Gonzalez, Claudio
author_role author
author2 Sanchez, Celinda
Bardales, Darío
González Alfaro, Juan
Torres Samamé, Liliana
Burga, José Luis
Olmos, Cecil
Torres-Aparcana, Harold
Barreda, Luis
Delgado, Cesar
Garcia, Alfredo
Noriega-Ruiz, Víctor
Antezana, Antezana
Orengo, Juan C.
La Rosa, Alberto M.
Pinzón, Adolfo
Gonzalez, Claudio
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Diabetes Mellitus
Type 2
Glycated Hemoglobin
Follow-Up Studies
Peru
topic Diabetes Mellitus
Type 2
Glycated Hemoglobin
Follow-Up Studies
Peru
description Objective: To estimate the rate of subjects with type 2 diabetes mellitus (T2DM) who reach the therapy goal for HbA1C one year after diagnosis (early metabolic control). Methods: This was a retrospective study reviewing clinical records of adults who came to sixteen health centers distributed in nine Peruvian cities. Patients who received an initial T2DM diagnosis and who had at least one-year follow-up were included. Metabolic goals set in ADA 29018 standards were considered.     Results: Four hundred and fifty-seven subjects (53,03% female) were included. When diagnosed, their mean age was 55,75 years (standard deviation [SD]: ± 12,92), and mean HbA1C value was 9,10% (SD: ± 2,28). Concomitant diagnosis including high blood pressure or dyslipidemia were found in 27,13% and 52,40% of all subjects, respectively. After one-year follow-up, 57,76% of all subjects achieved the HbA1C goal (<7,0%). Goal achievement for other parameters were 39,66% for LDL-C (<100 mg/dl), 55,56% for HDL-C in males (>40 mg/dL), 24,31% for HDL-C in females (>50 mg/dL), 48,24% for triglycerides (<150 mg/dL), and 89,23 for blood pressure (<140/90 mm Hg).   Conclusions: In this real-life study performed in T2DM adults and with one year follow-up, reaching an appropriate goal for HbA1c (<7%) was achieved by 58% of all subjects. Although these results are compatible with reports from nearby regions, an opportunity is evidenced for improving early goal achievement with the objective of obtaining better results in the short term.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-08
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2554
10.35663/amp.2023.401.2554
url https://amp.cmp.org.pe/index.php/AMP/article/view/2554
identifier_str_mv 10.35663/amp.2023.401.2554
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2554/1507
dc.rights.none.fl_str_mv Copyright (c) 2023 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 40 No 1 (2023): January - March
ACTA MEDICA PERUANA; Vol. 40 Núm. 1 (2023): Enero - Marzo
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075112262139904
spelling Achieving early metabolic control in adults with type diabetes mellitus in PeruLogro de control metabólico temprano en adultos con diabetes mellitus tipo 2 en Perú Rocca Nación, JesusSanchez, CelindaBardales, DaríoGonzález Alfaro, JuanTorres Samamé, LilianaBurga, José LuisOlmos, CecilTorres-Aparcana, HaroldBarreda, LuisDelgado, CesarGarcia, AlfredoNoriega-Ruiz, VíctorAntezana, AntezanaOrengo, Juan C.La Rosa, Alberto M.Pinzón, AdolfoGonzalez, ClaudioDiabetes MellitusType 2Glycated HemoglobinFollow-Up StudiesPeruObjective: To estimate the rate of subjects with type 2 diabetes mellitus (T2DM) who reach the therapy goal for HbA1C one year after diagnosis (early metabolic control). Methods: This was a retrospective study reviewing clinical records of adults who came to sixteen health centers distributed in nine Peruvian cities. Patients who received an initial T2DM diagnosis and who had at least one-year follow-up were included. Metabolic goals set in ADA 29018 standards were considered.     Results: Four hundred and fifty-seven subjects (53,03% female) were included. When diagnosed, their mean age was 55,75 years (standard deviation [SD]: ± 12,92), and mean HbA1C value was 9,10% (SD: ± 2,28). Concomitant diagnosis including high blood pressure or dyslipidemia were found in 27,13% and 52,40% of all subjects, respectively. After one-year follow-up, 57,76% of all subjects achieved the HbA1C goal (<7,0%). Goal achievement for other parameters were 39,66% for LDL-C (<100 mg/dl), 55,56% for HDL-C in males (>40 mg/dL), 24,31% for HDL-C in females (>50 mg/dL), 48,24% for triglycerides (<150 mg/dL), and 89,23 for blood pressure (<140/90 mm Hg).   Conclusions: In this real-life study performed in T2DM adults and with one year follow-up, reaching an appropriate goal for HbA1c (<7%) was achieved by 58% of all subjects. Although these results are compatible with reports from nearby regions, an opportunity is evidenced for improving early goal achievement with the objective of obtaining better results in the short term.Objetivo: Estimar la proporción de sujetos con diabetes mellitus tipo 2 (DMT2) que alcanzan la meta terapéutica para HbA1C un año después del diagnóstico. Métodos: Revisión retrospectiva de historias clínicas de adultos atendidos en nueve ciudades peruanas.  Se incluyeron pacientes que recibieron un diagnóstico inicial de DMT2 y tuvieron al menos un año de seguimiento. Resultados:  Se incluyeron 457 sujetos (53,03% mujeres). Cuando fueron diagnosticados, la edad media fue de 55,75 años (DE ± 12,92), la media de HbA1C fue de 9,10% (DE ± 2,28). Hubo diagnóstico concomitante de hipertensión arterial o de dislipidemia en 27,13% y 52,40%, respectivamente. Al año de seguimiento, 57,76% de los sujetos alcanzó la meta de HbA1C (<7,0%). El logro de metas en otros parámetros fue 39,66% para LDL-c (<100 mg / dL), 55.56% para HDL-c en hombres (> 40 mg / dL), 24.31% para HDL-c en mujeres (>50 mg/dL), 48.24% para triglicéridos (<150 mg/dL), y 89,23% para presión arterial (<140/90 mmHg).       Conclusiones: En este estudio en condiciones de la vida real, en adultos con DMT2 con un año de seguimiento, el logro de la meta de HbA1c (<7%) se alcanzó en el 58% de los pacientes. Si bien estos resultados son compatibles con los reportados en otros estudios de la región, se evidencia la oportunidad de mejorar el logro temprano de metas con el objetivo de optimizar los resultados a largo plazo.   Colegio Médico del Perú2023-05-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/255410.35663/amp.2023.401.2554ACTA MEDICA PERUANA; Vol 40 No 1 (2023): January - MarchACTA MEDICA PERUANA; Vol. 40 Núm. 1 (2023): Enero - Marzo1728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2554/1507Copyright (c) 2023 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/25542023-07-06T03:35:44Z
score 13.95948
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).